Hisamitsu Pharmaceutical Co (JP:4530) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Hisamitsu Pharmaceutical Co. has reported a 12.7% increase in net sales and an 8.1% increase in profits attributable to owners for the second quarter of the fiscal year ending February 2025. Despite a decrease in ordinary profit, the company maintained a strong shareholders’ equity ratio of 78.0% and plans to pay a commemorative dividend for the company’s 90th anniversary. The full-year forecast anticipates continued growth with a 7.3% increase in net sales and a 13.1% increase in profit attributable to owners.
For further insights into JP:4530 stock, check out TipRanks’ Stock Analysis page.
